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BIOLOGICAL RATIONALE
Periodontitis is a multifactorial disease that is associated with loss of the supporting tissues (ie, periodontal ligament and alveolar bone) around the tooth. 1 A major objective of periodontal therapy is to remove soft and hard, supragingival and subgingival deposits from the root surface in order to stop disease progression. 2 Numerous studies have reported significant improvements of clinical and microbial parameters following nonsurgical periodontal therapy. [3] [4] [5] [6] Despite that nonsurgical periodontal treatment may result in significant clinical improvements in the great majority of cases, evidence indicates that none of the currently available instrumentation techniques are effective in completely eliminating subgingival bacterial biofilm. 7 These limitations may be attributed to several factors, such as the complex anatomy of teeth (ie, furcation involvements, root invaginations); the presence of intrabony defects, and others; mechanical limitations related to the size of instruments, or invasion of periodontal pathogens into the surrounding soft tissues, or possible recolonization of periodontal pockets from other diseased sites or intraoral niches. 8 Power-driven instruments (ie, sonic and ultrasonic scalers) have been introduced to further enhance the effectiveness of scaling and root planing (SRP). However, findings from clinical studies have also shown comparative outcomes following power-driven and manual instrumentation. 9 Thus, the current evidence indicates that nonsurgical periodontal treatment may result in substantial clinical improvements in most cases, but none of the currently available instrumentation techniques are able to completely eliminate subgingival bacteria and calculus. 7 Photodynamic therapy (PDT), also called photoradiation therapy, phototherapy, photochemotherapy, photo-activated disinfection (PAD), or light-activated disinfection (LAD), was introduced in medical therapy in 1904 as the light-induced inactivation of cells, microorganisms, or molecules and involves the combination of visible light, usually through the use of a diode laser and a photosensitizer. 10 The photosensitizer ( Fig. 1) is a substance that is capable of absorbing light of a specific wavelength and transforming it into useful energy. Each factor is harmless by itself, but when combined, can produce lethal cytotoxic agents that can selectively destroy cells. 11 Thus, PDT has been proposed as a modality to reduce bacterial load or even to eliminate periodontal pathogens. 12, 13 Fig. 1 . Application of the phenothiazine chloride dye following subgingival SRP.
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The action mechanism of PDT has been extensively described previously.
14 Briefly, on illumination (Fig. 2) , the photosensitizer (See Fig. 1 ) is excited from the ground state to the triplet state. The longer lifetime of the triplet state enables the interaction of the excited photosensitizer with the surrounding molecules. It is anticipated that the generation of the cytotoxic species produced during PDT occurs while in this state. 15, 16 The cytotoxic product, usually singlet oxygen ( 1 O 2 ), cannot migrate at a distance more than 0.02 mm after its formation, thus making it ideal for local application of PDT, without endangering distant molecules, cells, or organs. 16 In vitro studies have revealed that light from a Helium/Neon (He/Ne) laser or a Gallium-Aluminum-Arsenide (GaAlAs) laser, in combination with appropriate photosensitizers, can achieve a significant reduction in the viability of both aerobic and anaerobic bacteria in a solution of subgingival plaque from patients with chronic periodontitis (ChP). 17, 18 Dobson and Wilson 19 have shown that bacteria associated with periodontal disease can be killed through photosensitization with Toluidine blue-O and irradiation with a He/Ne soft laser. Subsequent studies in animals have shown PDT was distinctly advantageous in reducing the periodontal signs of redness and bleeding on probing (BOP), and significantly suppressed Porphyromonas gingivalis. 20 During the last decade, considerable interest has evolved in evaluating the use of PDT in the treatment of periodontal and peri-implant infections. However, despite the relatively abundant literature, the data on the clinical relevance of PDT when used in conjunction with mechanical therapy are still controversial and difficult to interpret for the clinician. Therefore, the aims of this review article are (a) to provide an overview of the current evidence from randomized controlled clinical studies (RCTs) evaluating the potential clinical benefit for the additional use of PDT to mechanical debridement alone in nonsurgical periodontal therapy; and (b) to provide clinical recommendations for the use of PDT in periodontal practice.
USE OF PHOTODYNAMIC THERAPY AS ADJUNCT TO NONSURGICAL PERIODONTAL THERAPY IN PATIENTS WITH UNTREATED CHRONIC PERIODONTITIS
A total of 18 RCTs have compared the potential additional benefit of PDT to SRP with the use of SRP alone in untreated periodontitis patients ( Table 1) . Eight of the 18 studies have reported statistically significantly higher improvements in probing depth (PD) reduction and clinical attachment (CAL) gain following SRP 1 PDT compared with SRP alone, [21] [22] [23] [24] [25] [26] [27] [28] whereas the rest of 10 studies have failed to reveal statistically Photodynamic Therapy in Periodontal Treatment Abbreviations: A.a., Aggregatibacter actinomycetemcomitans; C.r., Campylobacter rectus; C.s., Capnocytophaga spp; E.c., Eikenella corrodens; E.n., Eubacterium nodatum; F.n., Fusobacterium nucleatum; IFN-g, interferon g; *, statistical significant value; n.r., not reported; n.s., not significant; P.g., Porphyromonas gingivalis; P.i., Prevotella intermedia; P.m., Parvimonas micra; REC, recession; T.d., Treponema denticola; T.f., Tannerella forsythia. Data from Refs. [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] significant differences in these parameters. [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] An additional improvement for the reduction of bleeding on probing (BOP) following the use of PDT was reported in 5 of the 19 papers. 22, 26, 28, 31, 32 Changes of microbiological parameters were evaluated in 8 of 18 studies. Four studies have found a statistically significant effect of the additional use of PDT on the reduction of periodontal pathogens, 28, 35, 37, 38 whereas 4 studies have failed to reveal any differences between the treatments groups. 31, 33, 36, 39 Three of the 18 studies have also evaluated the changes in terms of various inflammatory markers. 29, 33, 34 All 3 studies have revealed statistically significantly higher reductions in the investigated inflammatory markers following the additional use of PDT (see Table 1 ).
USE OF PHOTODYNAMIC THERAPY AS ADJUNCT TO NONSURGICAL PERIODONTAL THERAPY IN PATIENTS WITH AGGRESSIVE PERIODONTITIS
Two RCTs have compared treatment with SRP 1 PDT to treatment with SRP alone, 40, 41 and another study has compared SRP alone to PDT alone (ie, without any mechanical debridement) ( Table 2) . 42, 43 Although one study found statistically significant improvements in terms of PD reduction and CAL gain in deep pockets (PD !7 mm) and significantly less periodontal pathogens of the red and orange complex and interleukin (IL)-1b/IL-10 ratio following treatment with PDT, 41 another study failed to reveal any statistically significant differences in the evaluated clinical and microbiological parameters between the treatments (see Table 2 ).
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USE OF PHOTODYNAMIC THERAPY AS AN ADJUNCT TO NONSURGICAL PERIODONTAL THERAPY IN MAINTENANCE PERIODONTITIS PATIENTS
Eight RCTs have evaluated the potential additional benefit of PDT to SRP as compared with the use of SRP alone in maintenance patients ( Table 3) . Two of the 8 studies have reported statistically significantly improvements in PD reduction and CAL gain following SRP 1 PDT compared with SRP alone. 44, 45 An additional improvement for the reduction of BOP was reported in 5 of the 8 studies. [44] [45] [46] [47] [48] Although 3 studies found a statistically significant effect of the additional use of PDT on the reduction of periodontal pathogens, [46] [47] [48] 3 other studies failed to reveal statistically significant differences between the treatment groups. [49] [50] [51] Three of the 8 studies have also evaluated the changes in terms of inflammatory markers. 47, 50, 52 Two studies found statistically significantly higher reductions in the investigated inflammatory markers following the use of PDT, 47, 50 whereas one study detected no differences (see Table 3 ).
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USE OF PHOTODYNAMIC THERAPY AS AN ALTERNATIVE TO SYSTEMIC OR LOCAL ANTIBIOTICS
An extremely important aspect that must be kept in mind when considering the use of PDT is the lack of bacterial resistance to the antimicrobial mechanism, which gains even more importance in the light of the worldwide increase in bacterial resistance against conventional antibiotics. 53 Thus, its repeated application in conjunction with mechanical debridement may represent a valuable future option for treating periodontal and peri-implant infections. 11, 54 At present, there is, however, limited evidence on the possibility of PDT to replace systemic or local antibiotics.
A recent RCT study evaluated the treatment of patients with aggressive periodontitis (AgP) by means of nonsurgical periodontal therapy in conjunction with either systemic administration of amoxicillin and metronidazole or 2 times topical application Abbreviations: A.a., Aggregatibacter actinomycetemcomitans; C.r., Campylobacter rectus; C.s., Capnocytophaga spp; E.c., Eikenella corrodens; E.n., Eubacterium nodatum; F.n., Fusobacterium nucleatum; *, statistical significant value; n.r., not reported; n.s., not significant; P.g., Porphyromonas gingivalis; P.i., Prevotella intermedia; P.m., Parvimonas micra; T.d., Treponema denticola; T.f., Tannerella forsythia.
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Data from Refs. [40] [41] [42] [43] Photodynamic Therapy in Periodontal Treatment A.a., P.g., P.i., T.f., T.d., P.m., F.n., C.r., E.n., E.c., C.s. Abbreviations: A.a., Aggregatibacter actinomycetemcomitans; b-FGF, basic fibroblast growth factor; C.r., Campylobacter rectus; C.s., Capnocytophaga spp; E.c., Eikenella corrodens; E.n., Eubacterium nodatum; F.n., Fusobacterium nucleatum; G-CSF, granulocyte colony stimulating factor; GM-CSF, granulocyte macrophage colony stimulating factor; IFN-g, interferon g; MIP-1b, macrophage inflammatory protein 1b; *, statistical significant value; n.r., not reported; n.s., not significant; P.g., Porphyromonas gingivalis; P.i., Prevotella intermedia; P.m., Parvimonas micra; REC, recession; T.d., Treponema denticola; T.f., Tannerella forsythia; TNF-a, tumor necrosis factor a; VEGF, vascular endothelial growth factor. Data from Refs. [44] [45] [46] [47] [48] [49] [50] [51] [52] of PDT. 55, 56 The results found that both treatment protocols resulted in statistically significant improvements in PD reduction, gain of CAL, and improvement in BOP compared with baseline. The systemic use of amoxicillin and metronidazole yielded, however, at both 3 and 6 months, statistically significantly higher reductions in mean PD compared with the treatment using PDT. 55, 56 The most important clinical finding was the change in the total number of pockets 7 mm or greater following both treatment protocols. In the PDT group, the total number of pockets 7 mm or greater was reduced from 137 to 45 with the corresponding values of 141 and 3 in the amoxicillin and metronidazole group. Moreover, compared with the results at 3 months, at 6 months, an additional decrease in the number of pockets 7 mm or greater was measured. 55, 56 On the other hand, the use of PDT also led to statistically and clinically significant improvements compared with baseline, although the number of residual pockets needing further therapy was substantially higher compared with the use of systemic antibiotics (eg, 45 vs 3). The changes in clinical parameters were also accompanied by changes in the concentration of matrix metalloproteinases 8 and 9 (MMP-8 and -9) in the gingival crevicular fluid (GCF). 57 However, although in the antibiotic group, a statistically significant decrease of MMP-8 GCF level at both 3 and 6 months after treatment was observed, these changes were not significant in the PDT group. 57 Taken together, the available data suggest a limited clinical benefit in using PDT for the treatment of patients with AgP. 40, 42, 43, 56, 57 Thus, presently, PDT cannot be recommended as a replacement for systemic antibiotics in patients with AgP. On the other hand, no studies have compared the use of PDT or systemic antibiotics in conjunction with nonsurgical treatment in patients with ChP.
The use of PDT as a potential alternative to local antibiotics has been recently evaluated in an RCT study comparing nonsurgical treatment of incipient peri-implantitis (sites with PD 4-6 mm, BOP positive, and radiographic bone loss !2 mm) by means of mechanical debridement followed by either the use of local antibiotics (eg, minocycline) or the application of PDT. The results at 6 months and at 1 year failed to reveal statistically or clinically significant differences between the 2 treatment protocols, thus suggesting that PDT may represent a valuable alternative to local antibiotics during nonsurgical treatment of incipient peri-implantitis.
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SUMMARY Based on the available evidence from RCTs, the following conclusions can be drawn:
In patients with ChP, the combination of SRP and PDT may result in substantially higher short-term clinical improvements evidenced by PD and BOP reductions compared with SRP alone. In patients with AgP, the use of PDT cannot replace the systemic administration of amoxicillin and metronidazole. Because of the lack of data, no conclusions can be made to what extent PDT may replace the use of systemic antibiotics in patients with ChP. Limited evidence from one study indicates that PDT may represent a possible alternative to local antibiotics in patients with incipient peri-implantitis.
CLINICAL RECOMMENDATIONS
1. In patients with ChP, clinicians may consider the use of PDT in conjunction with subgingival mechanical debridement. However, because of limitations in time and costs, the use of PDT appears to be more suitable in the maintenance phase of therapy. 
